The Procter & Gamble Company (NYSE:PG) Shares Acquired by Intrust Bank NA

Intrust Bank NA increased its position in The Procter & Gamble Company (NYSE:PGFree Report) by 0.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,024 shares of the company’s stock after acquiring an additional 87 shares during the period. Intrust Bank NA’s holdings in Procter & Gamble were worth $2,934,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Demars Financial Group LLC grew its holdings in shares of Procter & Gamble by 4.4% in the 4th quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock worth $219,000 after acquiring an additional 63 shares during the period. Emerald Advisors LLC grew its holdings in Procter & Gamble by 1.8% during the 4th quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock valued at $553,000 after buying an additional 65 shares during the last quarter. O Brien Wealth Partners LLC grew its holdings in Procter & Gamble by 3.3% during the 4th quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock valued at $302,000 after buying an additional 65 shares during the last quarter. KFA Private Wealth Group LLC grew its holdings in Procter & Gamble by 2.2% during the 3rd quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock valued at $445,000 after buying an additional 67 shares during the last quarter. Finally, Chemistry Wealth Management LLC boosted its holdings in shares of Procter & Gamble by 1.2% during the fourth quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock worth $856,000 after purchasing an additional 67 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Price Performance

NYSE:PG traded up $0.37 during midday trading on Monday, hitting $161.66. 4,620,881 shares of the stock were exchanged, compared to its average volume of 6,909,636. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $164.32. The company has a market capitalization of $381.54 billion, a price-to-earnings ratio of 26.29, a P/E/G ratio of 3.27 and a beta of 0.44. The business has a 50-day moving average price of $159.64 and a two-hundred day moving average price of $153.65. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.42 by $0.10. The firm had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm’s quarterly revenue was up .6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.37 earnings per share. Sell-side analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $1.0065 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.49%. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is currently 65.85%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the company’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, CEO Gary A. Coombe sold 22,000 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the transaction, the chief executive officer now directly owns 36,845 shares in the company, valued at approximately $5,943,835.40. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 28,369 shares of the business’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the transaction, the insider now owns 11,507 shares in the company, valued at $1,858,265.43. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 55,865 shares of company stock valued at $9,009,280. Corporate insiders own 0.17% of the company’s stock.

Wall Street Analysts Forecast Growth

PG has been the topic of several analyst reports. JPMorgan Chase & Co. decreased their price objective on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a report on Thursday, January 18th. UBS Group increased their target price on Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft cut their target price on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research report on Monday, April 22nd. Stifel Nicolaus raised their price objective on Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research report on Wednesday, January 24th. Finally, Wells Fargo & Company raised their price objective on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research report on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $169.76.

View Our Latest Research Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.